Balance Sheet Insights: CryoPort Inc (CYRX)’s Debt-to-Equity and Long-Term Debt/Eq Ratios

Kevin Freeman

In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.

In other words, the price has increased by $0.00 from its previous closing price. On the day, 0.61 million shares were traded. CYRX stock price reached its highest trading level at $9.37 during the session, while it also had its lowest trading level at $9.11.

Ratios:

For a deeper understanding of CryoPort Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 15.01 and its Current Ratio is at 15.77. In the meantime, Its Debt-to-Equity ratio is 0.45 whereas as Long-Term Debt/Eq ratio is at 0.44.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 10 ’25 when Mandalam Ramkumar sold 11,570 shares for $9.99 per share. The transaction valued at 115,540 led to the insider holds 80,758 shares of the business.

RAMKUMAR MANDALAM bought 11,570 shares of CYRX for $115,540 on Dec 10 ’25. On Sep 11 ’25, another insider, Hariri Robert J, who serves as the Director of the company, sold 25,000 shares for $9.71 each. As a result, the insider received 242,738 and left with 51,275 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CYRX now has a Market Capitalization of 462636672 and an Enterprise Value of 312457664. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.43 while its Price-to-Book (P/B) ratio in mrq is 0.98. Its current Enterprise Value per Revenue stands at 1.282 whereas that against EBITDA is -15.744.

Stock Price History:

The Beta on a monthly basis for CYRX is 1.55, which has changed by 0.18613613 over the last 52 weeks, in comparison to a change of 0.16081822 over the same period for the S&P500. Over the past 52 weeks, CYRX has reached a high of $11.44, while it has fallen to a 52-week low of $4.58. The 50-Day Moving Average of the stock is -1.75%, while the 200-Day Moving Average is calculated to be 18.78%.

Shares Statistics:

For the past three months, CYRX has traded an average of 660.85K shares per day and 575450 over the past ten days. A total of 50.07M shares are outstanding, with a floating share count of 47.82M. Insiders hold about 4.49% of the company’s shares, while institutions hold 93.95% stake in the company. Shares short for CYRX as of 1764288000 were 3277722 with a Short Ratio of 4.96, compared to 1761868800 on 3138924. Therefore, it implies a Short% of Shares Outstanding of 3277722 and a Short% of Float of 7.8.

Earnings Estimates

The stock of CryoPort Inc (CYRX) is currently drawing attention from 3.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is -$0.14, with high estimates of -$0.02 and low estimates of -$0.2.

Analysts are recommending an EPS of between -$0.79 and -$0.86 for the fiscal current year, implying an average EPS of -$0.84. EPS for the following year is -$0.58, with 3.0 analysts recommending between -$0.38 and -$0.69.

Revenue Estimates

A total of 9 analysts believe the company’s revenue will be $42.93M this quarter.It ranges from a high estimate of $45.42M to a low estimate of $41.7M. As of. The current estimate, CryoPort Inc’s year-ago sales were $59.53MFor the next quarter, 9 analysts are estimating revenue of $44.54M. There is a high estimate of $45.27M for the next quarter, whereas the lowest estimate is $43M.

A total of 9 analysts have provided revenue estimates for CYRX’s current fiscal year. The highest revenue estimate was $176.15M, while the lowest revenue estimate was $172.4M, resulting in an average revenue estimate of $173.65M. In the same quarter a year ago, actual revenue was $228.38MBased on 9 analysts’ estimates, the company’s revenue will be $189.64M in the next fiscal year. The high estimate is $192.24M and the low estimate is $186.2M.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.